Deep-pocketed investors have adopted a bearish approach towards ResMed RMD, and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in RMD usually suggests something big is about to happen.
We gleaned this information from our observations today when Benzinga's options scanner highlighted 9 extraordinary options activities for ResMed. This level of activity is out of the ordinary.
The general mood among these heavyweight investors is divided, with 33% leaning bullish and 44% bearish. Among these notable options, 6 are puts, totaling $255,320, and 3 are calls, amounting to $86,720.
Latest Startup Investment Opportunities:
Projected Price Targets
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $185.0 to $220.0 for ResMed during the past quarter.
Volume & Open Interest Development
In terms of liquidity and interest, the mean open interest for ResMed options trades today is 236.5 with a total volume of 622.00.
In the following chart, we are able to follow the development of volume and open interest of call and put options for ResMed's big money trades within a strike price range of $185.0 to $220.0 over the last 30 days.
ResMed Call and Put Volume: 30-Day Overview
Biggest Options Spotted:
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|---|---|---|
| RMD | PUT | TRADE | BULLISH | 08/16/24 | $6.4 | $6.1 | $6.1 | $185.00 | $91.5K | 212 | 4 |
| RMD | PUT | SWEEP | NEUTRAL | 01/17/25 | $15.1 | $14.8 | $15.1 | $190.00 | $42.2K | 12 | 0 |
| RMD | PUT | TRADE | BEARISH | 01/17/25 | $15.1 | $14.1 | $15.1 | $190.00 | $33.2K | 12 | 196 |
| RMD | CALL | SWEEP | BEARISH | 12/20/24 | $8.1 | $7.9 | $7.9 | $220.00 | $33.1K | 45 | 0 |
| RMD | PUT | TRADE | BEARISH | 01/17/25 | $15.4 | $15.0 | $15.4 | $190.00 | $30.8K | 12 | 234 |
About ResMed
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.
Where Is ResMed Standing Right Now?
- With a trading volume of 3,479,087, the price of RMD is down by -0.08%, reaching $191.42.
- Current RSI values indicate that the stock is is currently neutral between overbought and oversold.
- Next earnings report is scheduled for 34 days from now.
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for ResMed with Benzinga Pro for real-time alerts.
Edge Rankings
Price Trend
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
